Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - oseltamivir phosphate, quantity: 59.1 mg (equivalent: oseltamivir, qty mg) - capsule, hard - excipient ingredients: titanium dioxide; croscarmellose sodium; povidone; sodium stearylfumarate; gelatin; pregelatinised maize starch; iron oxide black; purified talc; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide - talminex is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,talminex is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - oseltamivir phosphate, quantity: 39.4 mg (equivalent: oseltamivir, qty mg) - capsule, hard - excipient ingredients: gelatin; pregelatinised maize starch; titanium dioxide; iron oxide red; povidone; sodium stearylfumarate; iron oxide yellow; croscarmellose sodium; purified talc; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - talminex is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,talminex is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - oseltamivir phosphate, quantity: 98.5 mg (equivalent: oseltamivir, qty mg) - capsule, hard - excipient ingredients: iron oxide red; croscarmellose sodium; purified talc; iron oxide black; gelatin; titanium dioxide; pregelatinised maize starch; iron oxide yellow; sodium stearylfumarate; povidone; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide - talminex is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,talminex is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - oseltamivir phosphate, quantity: 98.5 mg (equivalent: oseltamivir, qty 75 mg) - capsule, hard - excipient ingredients: pregelatinised maize starch; purified talc; povidone; croscarmellose sodium; sodium stearylfumarate; titanium dioxide; purified water; iron oxide yellow; iron oxide red; gelatin; iron oxide black; indigo carmine; butan-1-ol; ethanol; shellac; methanol - tamiflu is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,tamiflu is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

Kanada - inglise - Health Canada

mint pharmaceuticals inc - oseltamivir (oseltamivir phosphate) - capsule - 30mg - oseltamivir (oseltamivir phosphate) 30mg - neuraminidase inhibitors

Kanada - inglise - Health Canada

mint pharmaceuticals inc - oseltamivir (oseltamivir phosphate) - capsule - 45mg - oseltamivir (oseltamivir phosphate) 45mg - neuraminidase inhibitors

Kanada - inglise - Health Canada

mint pharmaceuticals inc - oseltamivir (oseltamivir phosphate) - capsule - 75mg - oseltamivir (oseltamivir phosphate) 75mg - neuraminidase inhibitors

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - oseltamivir phosphate, quantity: 98.524 mg - capsule, hard - excipient ingredients: croscarmellose sodium; ethanol absolute; sodium stearylfumarate; pregelatinised maize starch; purified talc; povidone; titanium dioxide; purified water; iron oxide yellow; gelatin; iron oxide black - oseltamivir is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,oseltamivir is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - oseltamivir phosphate, quantity: 39.41 mg - capsule, hard - excipient ingredients: pregelatinised maize starch; purified talc; ethanol absolute; sodium stearylfumarate; povidone; croscarmellose sodium; titanium dioxide; purified water; iron oxide yellow; gelatin - oseltamivir is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,oseltamivir is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - oseltamivir phosphate, quantity: 59.114 mg - capsule, hard - excipient ingredients: ethanol absolute; croscarmellose sodium; pregelatinised maize starch; purified talc; povidone; sodium stearylfumarate; titanium dioxide; purified water; gelatin; iron oxide black - oseltamivir is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,oseltamivir is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.